<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0134">
 <label>134</label>
 <element-citation publication-type="journal" id="sbref0134">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>F.C.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.H.</given-names>
   </name>
   <name>
    <surname>Guan</surname>
    <given-names>X.H.</given-names>
   </name>
   <name>
    <surname>Hou</surname>
    <given-names>L.H.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W.J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.X.</given-names>
   </name>
  </person-group>
  <article-title>Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial</article-title>
  <source>Lancet</source>
  <volume>395</volume>
  <year>2020</year>
  <fpage>1845</fpage>
  <lpage>1854</lpage>
  <pub-id pub-id-type="pmid">32450106</pub-id>
 </element-citation>
</ref>
